Welcome to DIAN, led by WashU Medicine. By researching dominantly inherited Alzheimer’s disease (DIAD), we are committed to pushing the bounds of medicine and improving health in our community and around the world.
International participation in long-term observational studies and well as basic science studies and clinical trials help develop better methods of diagnosis, treatment and prevention of DIAD.
Get Involved
Families & Individuals
Learn about our observational study and clinical trials.
The expanded registry allows access to family conferences, genetic testing, and more!
Healthcare Professionals
- Learn about our observational study and clinical trials.
- Join the registry to receive our newsletter and refer your patients.
- Questions? Contact us
How does Alzheimer’s disease progress over time?
By observing participants over a period of time, we study disease progression and find ways to treat and prevent the disease.
Clinical drug trials are available for individuals who have or are at risk for dominantly inherited Alzheimer’s disease.
Which drugs can potentially change the course of DIAD?
Featured DIAN News
New drug targets for Alzheimer’s identified from cerebrospinal fluid (Links to an external site)
A Country Doctor, But Oh So Much More: Francisco Lopera, 73 (Links to an external site)
First Success Stories From Alzheimer’s Secondary Prevention Trial (Links to an external site)
Your participation and support can help us find ways to diagnose, treat and prevent inherited and other forms of Alzheimer’s disease.